ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $661K of Zentalis Pharmaceuticals, Inc.
Sold$661,490
$66.15Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Tue, Oct 5 open, $66.94
- +15.1%
- S&P 500, same days
- +9.1%
Measured over 30 trading days, to the Nov 16 close.
Traded Fri, Oct 1. Filed Mon, Oct 4, 5:17 PM ET, after the close. Returns use the Oct 5 open and the Nov 16 close. Not investment advice.